CSIMarket
 


Lifeloc Technologies Inc   (LCTC)
Other Ticker:  
 

Lifeloc Technologies Inc 's Working Capital Ratio

LCTC's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth

 


Regardless of the sequential decrease in Current Liabilities, during the first quarter 2024, Working Capital Ratio deteriorated to 5.59 below Lifeloc Technologies Inc 's average Working Capital Ratio.

Within Laboratory Analytical Instruments industry 9 other companies have achieved higher Working Capital Ratio than Lifeloc Technologies Inc in first quarter 2024. While Working Capital Ratio total ranking in the first quarter 2024 has deteriorated compared to the prior quarter from 764 to 803.

Explain Working Capital Ratio
How much Current Assetss LCTC´s has?
What are LCTC´s Current Liabilities?


LCTC Working Capital Ratio (Mar 31 2024)
Q1
(Dec 31 2023)
Q4
(Sep 30 2023)
Q3
(Jun 30 2023)
Q2
(Mar 31 2023)
Q1
Y / Y Current Liabilities Change 5.17 % 1.92 % 15.27 % 11.21 % 38.92 %
Y / Y Current Assets Change -12.25 % -2.88 % 7.69 % 6.93 % 5.13 %
Working Capital Ratio MRQ 5.59 5.99 6.28 7.41 6.7
LCTC's Total Ranking # 803 # 764 # 540 # 312 # 491
Seq. Current Liabilities Change -4.9 % -0.54 % 22.67 % -9.35 % -7.85 %
Seq. Current Assets Change -11.15 % -5.22 % 4.08 % 0.12 % -1.67 %



Working Capital Ratio first quarter 2024 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 10
Healthcare Sector # 361
Overall Market # 803


Working Capital Ratio Statistics
High Average Low
10.39 6.4 4.07
(Sep 30 2021)   (Dec 31 2020)




Financial Statements
Lifeloc Technologies Inc 's Current Liabilities $ 1 Millions Visit LCTC's Balance sheet
Lifeloc Technologies Inc 's Current Assets $ 5 Millions Visit LCTC's Balance sheet
Source of LCTC's Sales Visit LCTC's Sales by Geography


Cumulative Lifeloc Technologies Inc 's Working Capital Ratio

LCTC's Working Capital Ratio for the trailling 12 Months

LCTC Working Capital Ratio

(Mar 31 2024)
12 Months
(Dec 31 2023)
12 Months
(Sep 30 2023)
12 Months
(Jun 30 2023)
12 Months
(Mar 31 2023)
12 Months
Y / Y Current Liabilities TTM Growth 8.05 % 15.05 % 15.39 % 21.83 % 0.6 %
Y / Y Current Assets TTM Growth -0.32 % 4.1 % 4.95 % 1.74 % -1.39 %
Working Capital Ratio TTM 6.27 6.55 6.63 6.75 6.8
Total Ranking TTM # 3783 # 329 # 498 # 3768 # 3776
Seq. Current Liabilities TTM Growth 1.25 % 0.51 % 3.72 % 2.36 % 7.81 %
Seq. Current Assets TTM Growth -3.04 % -0.72 % 1.87 % 1.66 % 1.26 %


On the trailing twelve months basis Due to decrease in Current Liabilities in the Q1 2024 to $0.91 millions, cumulative Working Capital Ratio decreased to 6.27 above the LCTC average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 29 other companies have achieved higher Working Capital Ratio than Lifeloc Technologies Inc . While Working Capital Ratio total ranking has deteriorated compared to the previous twelve months ending in the forth quarter 2023 from 329 to 3783.

Explain Working Capital Ratio
How much Current Assetss LCTC´s has?
What are LCTC´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 30
Healthcare Sector # 1003
Within the Market # 3783


trailing twelve months Working Capital Ratio Statistics
High Average Low
7.2 6.02 4.38
(Dec. 30, 2015)   (Mar 31 2021)




Companies with similar Working Capital Ratio in the quarter ending Mar 31 2024, within Laboratory Analytical Instruments Industry Working Capital RatioMar 31 2024 MRQ Current AssetsMar 31 2024 MRQ Current Liabilities
Quanterix Corporation  11.28 $ 369.352  Millions$ 32.757  Millions
Pacific Biosciences Of California Inc   9.28 $ 677.024  Millions$ 72.951  Millions
Talis Biomedical Corporation  7.51 $ 71.170  Millions$ 9.471  Millions
Bio rad Laboratories Inc   7.18 $ 3,060.936  Millions$ 426.116  Millions
Cytek Biosciences Inc   6.99 $ 388.647  Millions$ 55.566  Millions
Rapid Micro Biosystems Inc   6.93 $ 108.160  Millions$ 15.600  Millions
Lifeloc Technologies Inc   5.59 $ 5.073  Millions$ 0.907  Millions
Scientific Industries Inc   5.56 $ 11.400  Millions$ 2.050  Millions
10x Genomics Inc   5.22 $ 567.093  Millions$ 108.733  Millions
Eyepoint Pharmaceuticals Inc   5.08 $ 317.709  Millions$ 62.580  Millions
Standard Biotools Inc   4.50 $ 547.565  Millions$ 121.554  Millions
Reflect Scientific Inc  3.66 $ 2.396  Millions$ 0.655  Millions
Telesis Bio Inc   3.65 $ 23.395  Millions$ 6.412  Millions
Akoya Biosciences Inc   3.07 $ 101.829  Millions$ 33.193  Millions
Kewaunee Scientific Corporation  2.37 $ 96.817  Millions$ 40.780  Millions
Revvity Inc   2.23 $ 3,059.340  Millions$ 1,374.222  Millions
Agilent Technologies inc   2.15 $ 4,203.000  Millions$ 1,958.000  Millions
Harvard Bioscience Inc   1.88 $ 48.148  Millions$ 25.677  Millions
Bruker Corporation  1.81 $ 2,140.400  Millions$ 1,182.500  Millions
Illumina Inc   1.75 $ 2,583.000  Millions$ 1,474.000  Millions
Avantor Inc   1.61 $ 2,321.100  Millions$ 1,441.900  Millions
Accelerate Diagnostics Inc   1.50 $ 24.133  Millions$ 16.131  Millions
Bionano Genomics Inc   1.46 $ 85.611  Millions$ 58.506  Millions
Mettler toledo International Inc   1.28 $ 1,211.114  Millions$ 948.759  Millions

Date modified: 2024-09-02T11:06:20+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com